Health Care & Life Sciences » Pharmaceuticals | Lionco Pharmaceutical Group Co. Ltd.

Lionco Pharmaceutical Group Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
488,865.30
569,672.50
543,661.50
472,186.00
988,623.10
1,645
Cost of Goods Sold (COGS) incl. D&A
212,033.40
241,261.70
232,865.80
213,971.40
215,078.40
221
Gross Income
276,831.90
328,410.90
310,795.80
258,214.60
773,544.70
1,424
SG&A Expense
147,974.50
164,996.10
155,082.30
145,477.30
647,412.60
1,292
EBIT
128,300.70
162,910.70
155,703.10
158,475.30
125,970.40
130
Unusual Expense
-
1,794.10
-
-
-
2
Non Operating Income/Expense
112.90
388.60
4,281.70
3,329.80
32,149.60
59
Interest Expense
125.40
330.30
4,883.10
651.40
147.40
2
Pretax Income
152,995.10
185,028.80
176,611.60
177,167.10
180,101.90
212
Income Tax
38,196.50
35,170.60
26,917.40
23,241.90
19,096.40
21
Consolidated Net Income
114,798.50
149,858.20
149,694.30
153,925.20
161,005.40
183
Net Income
114,798.50
149,858.20
149,694.30
153,925.20
161,005.40
183
Net Income After Extraordinaries
114,798.50
149,858.20
149,694.30
153,925.20
161,005.40
183
Net Income Available to Common
114,798.50
149,858.20
149,694.30
153,925.20
161,005.40
183
EPS (Basic)
0.31
0.41
0.46
0.42
0.44
0.36
Basic Shares Outstanding
364,000.40
364,000.40
326,083.70
364,000.40
364,000.40
510
EPS (Diluted)
0.32
0.41
0.46
0.42
0.44
0.36
Diluted Shares Outstanding
364,000.40
364,000.40
326,083.70
364,000.40
364,000.40
510
EBITDA
138,259.00
178,738.50
182,507.40
188,632.70
160,783.50
165
Other Operating Expense
556.70
504.00
10.40
45,738.10
161.80
3
Non-Operating Interest Income
1,163.60
2,280.00
21,534.40
20,935.30
22,129.30
25

About Lionco Pharmaceutical Group Co.

View Profile
Address
1/F, Commercial Building 2
Shannan Tibet 856000
China
Employees -
Website http://www.lingkang.com.cn
Updated 07/08/2019
Lionco Pharmaceutical Group Co., Ltd. engages in the sale of chemical drug and antibiotic agents. Its business operations include the development of medical device technology, and the investment and management of pharmaceutical industries. It products include chinese medicines and health care products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.